In moderate/severe NASH, high levels of hepatic RBP4 corelated with lobular inflammation and fibrosis scores [302], whereas other studies indicate that both serum and hepatic RBP4 levels negatively correlate with the liver fibrosis stage [299]. This evidence concerns the gene RBP4 and metabolic dysfunction-associated steatohepatitis.